Electrophysiological consequences of purinergic receptor stimulation in isolated rat pulmonary arterial myocytes

Circulation Research

Volumn 80, Issue 2, 1997, Pages 170-178

  Hartley, S Anthony ^a   Kozlowski, Roland Z ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cl channel; P2 purinoceptor; pulmonary artery; purine nucleotide

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CHLORIDE CHANNEL; CHLORIDE ION; PURINE P2 RECEPTOR; RECEPTOR SUBTYPE; SURAMIN; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; BLOOD VESSEL TONE; CHLORIDE CURRENT; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MEMBRANE ELECTROPHYSIOLOGY; NONHUMAN; PATCH CLAMP; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0031017329     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.2.170     Document Type: Article

References (54)

1. Forrester T, Williams CA. Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia. J Physiol (Lond). 1977;268:371-390.
2. Pearson JD, Gordon JL. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature. 1979;281:384-386.
3. Born GV, Kratzer MA. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol (Lond). 1984;354:419-429.
4. Ingerman CM, Smith LB, Silver MJ. Direct measurement of platelet secretion in whole blood. Thromb Res. 1979;16:335-344.
5. Burnstock G. Purinergic mechanisms. Ann N Y Acad Sci. 1990;603:1-17.
6. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16:433-440.
7. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA. Cloning and functional expression of a brain G-protein coupled ATP receptor. FEBS Lett. 1993;324:219-225.
8. Parr CE, Sullivan DM, Paradiso AM, Lazarowski ER, Burch LH, Olsen JC, Erb L. Weisman GA, Boucher RC, Turner JT. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacology. Proc Natl Acad Sci U S A. 1994;91:3275-3279.
9. 2-purinergic receptors for extracellular ATP: evidence for mediation by both pertussis toxin-sensitive and pertussis toxin-insensitive mechanisms. J Biol Chem. 1988;263:18108-18117.
10. 2Y-purinergic receptor. J Neurochem. 1990;55:1569-1575.
11. 2-purinergic agonists stimulate phospho- diesteratic cleavage of phosphatidyl choline in endothelial cells: evidence for activation of phospholipase D. J Biol Chem. 1989;264: 8847-8856.
12. 2purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of receptor subtype and of inositol triphosphate response. Mol Pharmacol. 1990;38:84-91.
13. 2+-permeable channel activated by ATP in smooth muscle. Nature. 1987;328:275-278.
14. Brake AJ, Wagenbach MJ, Julius D. A new structural motif for ligand-gated ion channels defined by an inotropic ATP receptor. Nature. 1994;371:519-523.
15. 2X receptor for extracellular ATP. Nature. 1994;371:516-519.
16. Bo X, Zhang Y, Nassar M, Burnstock G, Schoepfer R. A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 1995;375:129-133.
17. Chen C-C, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN. A P2X purinoceptor expressed by a subset of sensory neurones. Nature. 1995;377:428-431.
18. 2X6 receptors, and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci. 1996;16:2495-2507.
19. 2X ATP receptor ion channel with widespread distribution in the brain. J Neurosci. 1996;16:448-455.
20. 2-purinoceptor subtypes in the isolated perfused mesenteric bed of rat. Br J Pharmacol. 1988;95:637-645.
21. O'Connor SE, Dainty IA, Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci. 1991;12:137-141.
22. 2-purinoceptor subtypes in rat pulmonary vessels. J Pharmacol Exp Ther. 1989;251:1204-1210.
23. 2-purinoceptor subtypes in human small pulmonary arteries. Br J Pharmacol. 1989;98:1014-1020.
24. Lippton HL, Hao Q, Hauth T, Hyman AL. Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed. Am J Physiol. 1992;262:H926-H929.
25. Konduri GG, Theodorou AA, Mukhopadhyay A, Deshmukh DR. Adenosine triphosphate and adenosine increase the pulmonary blood flow to postnatal levels in fetal lambs. Pediatr Res. 1992;31:451-457.
26. Benumof JL, Fukunaga AF, Trousdale FR. ATP inhibits hypoxic pulmonary vasoconstriction. Anaesthesiology. 1982;57:A474. Abstract.
27. Gaba SJM, Bourgouin-Karaouni D, Dujols P, Michel FB, Prefaut C. Effects of adenosine triphosphate on pulmonary circulation in chronic obstructive pulmonary disease. ATP: a pulmonary vasoregulator? Am Rev Respir Dis. 1986;134:1140-1144.
28. Hassessian H, Bodin P, Burnstock G. Blockade by glibenclamide of the flow-evoked endothelial release of ATP that contributes to vasodilatation in the pulmonary vascular bed of the rat. Br J Pharmacol. 1993;109:466-472.
29. 3H] purine release from vascular adrenergic nerves: evidence for presynaptic autoinhibition. J Pharmacol Exp Ther. 1981;220:152-156.
30. Inoue T, Kannan MS. Nonadrenergic and noncholinergic excitatory neurotransmission in rat intrapulmonary artery. Am J Physiol. 1988;254:H1142-H1148.
31. + channel distribution in smooth muscle cells isolated from the pulmonary arterial tree of the rat. Biochem Biophys Res Commun. 1995;208:183-189.
32. Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol. 1988;92:145-159.
33. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.
34. Fabiato A. Buffering: computer programs and simulations. In: Mc- Cormack JG, Cobbold PH, eds. Cellular Calcium: A Practical Approach. New York, NY: Oxford University Press: 1991;159-175.
35. + channels and their modulation by endothelin-1 in the rat pulmonary arterial smooth muscle cells. Exp Physiol. 1995;80:815-824.
36. Kuriyama H, Kitamura K, Nabata H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol Rev. 1995;47:387-573.
37. Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ, Garcia ML. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Bathus tamulus. J. Biol Chem. 1990;265:11083-11090.
38. Hogg RC, Wang Q, Large WA. Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein. J Physiol (Lond). 1994;112:977-984.
39. Bennett CF, Mong S, Wu HL, Clark MA, Wheeler L, Crooke ST. Inhibition of phosphoinositide-specific phospholipase C by manoalide. Mol Pharmacol. 1987;32:587-593.
40. 2X-receptors in the rabbit isolated ear artery. Br J Pharmacol. 1990;101:645-649.
41. 2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br J Pharmacol. 1994;113:853-860.
42. Crack BE, Pollard CE, Beukers SM, Roberts SM, Hunt SF, Ingall AH, McKechnie KCW, Ijzerman AP, Leff P. Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br J Pharmacol. 1995;114:475-481.
43. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. J Pharmacol Exp Ther. 1994;46:143-156.
44. Abbrachio MP, Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther. 1994;64:445-475.
45. Lewis C, Neidhart S, Holy C, North RA, Buell G, Suprenant G. Heteropolymerization of P2X receptor subunits can account for ATP- gated currents in sensory neurones. Nature. 1995;377:432-435.
46. 2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol Sci. 1995;16:133-139.
47. - current in cultured smooth muscle cells from pig aorta. J Physiol (Lond). 1991;440:623-634.
48. Xiong Z, Kitamura K, Kuriyama H. ATP activates cationic currents and modulates the calcium current through GTP-binding protein in rabbit portal vein. J Physiol (Lond). 1991;440:143-165.
49. Benham CD. ATP-activated channels gate calcium entry in single smooth muscle cells dissociated from rabbit ear artery. J Physiol (Lond). 1989;419:689-701.
50. Zhang B-X, Ma X, McConnell BK, Damron DS, Bond M. Activation of purinergic receptors triggers oscillatory contractions in adult rat ventricular myocytes. Circ Res. 1996;79:94-102.
51. + currents in arterial myocytes. Biochem Biophys Res Commun. 1996;227:168-175.
52. Benham CD, Bolton TB, Byrne NG, Large WA. Action of externally applied adenosine triphosphate on single smooth muscle cells dispersed from rabbit ear artery. J Physiol (Lond). 1987;387: 473-488.
53. Katsuragi T, Tokunaga T, Ogawa S, Soejima O, Sato C, Furukawa T. Existence of ATP-evoked ATP release system in smooth muscles. J Pharmacol Exp Ther. 1991;259:513-518.
54. Burnstock G. Local mechanisms of blood flow control by perivascular nerves and endothelium. J Hypertens Suppl. 1990;8:S95-S106.